Safety and Efficacy of Abatacept Versus Placebo in Participants With Psoriatic Arthritis
Public ClinicalTrials.gov record NCT00534313. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase IIB, Multi-Dose, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Abatacept Versus Placebo in the Treatment of Psoriatic Arthritis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine an optimal abatacept dosing regimen for the treatment of active arthritis due to psoriatic arthritis in patients who have had a prior inadequate response to disease-modifying antirheumatic drugs, including methotrexate and tumor necrosis factor alpha-blockade compounds.
Study identification
- NCT ID
- NCT00534313
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 191 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2007 (Type not available)
- Primary completion
- Dec 2008 (Actual)
- Completion
- May 2011 (Actual)
- Last update posted
- Aug 1, 2012
2007 – 2011
United States locations
- U.S. sites
- 19
- U.S. states
- 13
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Rheumatology Associates Of North Alabama | Huntsville | Alabama | 35801 | — |
| Desert Medical Advances | Palm Desert | California | 92260 | — |
| Stanford University School Of Medicine | Palo Alto | California | 94304 | — |
| Boling Clinical Trials | Upland | California | 91786 | — |
| Joao Nascimento | Bridgeport | Connecticut | 06606 | — |
| New England Research Associates, Llc | Trumbull | Connecticut | 06611 | — |
| Sarasota Arthritis Research Center | Sarasota | Florida | 34239 | — |
| Clinical Pharmacology Study Group | Worcester | Massachusetts | 01610 | — |
| Justus Fiechtner, Md, Mph | Lansing | Michigan | 48910 | — |
| St. Paul Rheumatology P.A. | Eagan | Minnesota | 55121 | — |
| Midwest Arthritis Center | Kalamazoo | Minnesota | 49048 | — |
| Arthritis Clinic & Carolina Bone & Joint, Pa | Charlotte | North Carolina | 28210 | — |
| Deaconess Hospital | Cincinnati | Ohio | 45219 | — |
| Health Research Of Oklahoma | Oklahoma City | Oklahoma | 73103 | — |
| Altoona Center For Clinical Research | Duncansville | Pennsylvania | 16635 | — |
| Rheumatic Disease Associates, Ltd. | Willow Grove | Pennsylvania | 19090 | — |
| Chase, Walter F. | Austin | Texas | 78705 | — |
| Seattle Rheumatology Associates | Seattle | Washington | 98104 | — |
| Arthritis Northwest | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 25 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00534313, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 1, 2012 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00534313 live on ClinicalTrials.gov.